Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P3 and IGF2-P4 regulatory sequences.
Int J Clin Exp Med
; 4(2): 91-102, 2011.
Article
in En
| MEDLINE
| ID: mdl-21686134
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Int J Clin Exp Med
Year:
2011
Document type:
Article
Country of publication:
United States